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Objective: To investigate the independent associations of proteinuria and the estimated glomerular ﬁltration
rate (eGFR) with incident hypertension.
Methods:We investigated 29,181 Japanese males 18–59 years old without hypertension in 2000 and exam-
ined whether proteinuria and the eGFR predicted incident hypertension independently over 10 years. Incident
hypertension was deﬁned as a newly detected blood pressure of ≥140/90 mm Hg and/or the initiation of anti-
hypertensive drugs. Proteinuria and the eGFR were categorized as dipstick negative (reference), trace or ≥1+
and ≥60 (reference), 50–59.9 or b50 ml/min/1.73 m2, respectively. Cox proportional hazards models were
used to estimate the hazard ratios (HRs) of incident hypertension.
Results:At baseline, 236 (0.8%) and 477 (1.6%) participants had trace and≥1+dipstick proteinuria,while 1416
(4.9%) and 129 (0.4%) participants had an eGFR of 50–59.9 and b50 ml/min/1.73 m2, respectively. The adjusted
HRs were signiﬁcant for proteinuria ≥1+ (HRs 1.20, 95% CI: 1.06–1.35) and an eGFR of b50 ml/min/1.73 m2
(1.29, 1.03–1.61). When two non-referent categories were combined (dipstick ≥ trace vs. negative and
eGFR b 60 vs. ≥60 ml/min/1.73 m2), the association was more signiﬁcant for proteinuria (1.15, 1.04–1.27) than
for eGFR (0.99, 0.92–1.07).
Conclusions: Proteinuria and a reduced eGFR are independently associatedwith future hypertension in young to
middle-aged Japanese males.© 2013 The Authors. Published by Elsevier Inc. Open access under CC BY-NC-ND license.Introduction
Hypertension is a highly prevalent disorder that affects more than
one quarter of the population worldwide (Kearney et al., 2005) and is
a major risk factor for stroke, cardiovascular disease and end-stage
renal disease (Arima et al., 2003; Gueyfﬁer, 2003; Klag et al., 1996).
Hypertension is even more prevalent in Japan, with an estimated prev-
alence of ~40% (Kubo et al., 2008). Several factors, such as high sodium
intake (1988), obesity (Fox et al., 2007) and physical inactivity
(Dickinson et al., 2006), have been identiﬁed to be highly associatedMedicine in Cardiopulmonary
, 65, Tsurumai-cho, Showa-ku,
do).
c. Open access under CC BY-NC-ND licwith hypertension. However, approximately 90% of adults with hyper-
tension are considered to have essential hypertension, a conditionwith-
out an overt primary cause (Anderson et al., 1994; Carretero and Oparil,
2000; Nishikawa et al., 2007; Rossi et al., 2006).
The kidney plays a signiﬁcant role in the regulation of blood pressure
(BP) by controlling blood volume, the levels of electrolytes and the sym-
pathetic nervous system and hormonal systems, such as the renin–an-
giotensin–aldosterone system (Brewster and Perazella, 2004; Komukai
et al., 2010). Therefore, kidney damage and dysfunction, such as pro-
teinuria and a reduced glomerular ﬁltration rate (GFR), have attracted
attention as predictors of hypertension (Brantsma et al., 2006; Forman
et al., 2008; Gerber et al., 2006; Gueyfﬁer, 2003; Jessani et al., 2012;
Kestenbaum et al., 2008; Palatini et al., 2005; Takase et al., 2012;
Wang et al., 2005). However, to the best of our knowledge, only a few
studies have investigated the associations of proteinuria andGFR simul-
taneously with the development of hypertension, and the results were
not consistent (Kestenbaum et al., 2008; Takase et al., 2012), leaving
uncertainty regarding the respective contributions of these factors to
the development of hypertension. Asians, a racial/ethnic group with aense.
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2008), are particularly understudied regarding this issue.
Therefore, the purpose of the present studywas to investigate the in-
dependent association of the presence of proteinuria and a reduced
eGFR with incident hypertension in a prospective cohort study of
young to middle-aged Japanese males with annual BP evaluation.
Materials & methods
Study population
The study subjects included Japanesemaleswho underwent annualmedical
checkups at their workplaces, all of which were blue-chip companies in Japan
(Kondo et al., 2013; Yamashita et al., 2012). Japanese males 16–59 years of
age (n = 33,914) were recruited in 2000. We excluded participants with
preexisting hypertension (systolic BP ≥ 140 mm Hg, diastolic BP ≥ 90 mm Hg
or the use of antihypertensive drugs; n = 4688 at baseline examination) and
excluded participants aged b18 years old (n = 45), with a ﬁnal sample of
29,181 participants.
Data collection and measurements
Annual medical checkups including blood test and dipstick urine test were
conducted through 2010 or until retirement at around 60 years of age. All par-
ticipants were individually interviewed using a structured questionnaire in the
baseline and annual follow-up surveys. The following informationwas recorded
by trained observers: smoking status, alcohol intake, medical history and
medications. The smoking status and alcohol intake were classiﬁed as current
vs. former/never. Weight and height were measured while the subject was
wearing light clothing without shoes. The body mass index (BMI) was com-
puted as the weight in kilograms divided by the square of the height in meters.
Urine and blood samples were obtained in the morning with overnight fasting.
A urinalysis for proteinuria was conducted with Uropaper III (Eiken Chemical
Co., Ltd., Tokyo, Japan), and the results were measured using a US-2100 Auto-
mated Urine Analyzer (trace (±) corresponds to proteinuria ≥15 mg/dl, 1+ to
≥30 mg/dl, 2+ to ≥100 mg/dl, 3+ to ≥300 mg/dl and 4+ to ≥1000 mg/dl).
The blood analyseswere conducted at a single laboratory. The GFRwas estimated
using the three-variable equation proposed by the Japanese Society ofNephrology
(eGFR [ml/min/1.73 m2] = 194 × serum creatinine−1.094 × age−0.287 × 0.739Table 1
Baseline characteristics (dipstick negative, ±, ≥+ and eGFR ≥ 60, 50–59.9, b50 ml/min/1.73 m
Total
(n = 29,181)
Proteinuria
Negative
(n = 28,468)
Trace (±)
(n = 236)
Age (years old) 35 (30–40) 36 (31–43) 39 (31–50)
Body mass index (kg/m2) 22.3 22.4 22.7
(20.6–24.3) (20.6–24.3) (20.8–25.1)
Systolic blood pressure (mm Hg) 114 114 117
(106–121) (106–122) (108–126)
Diastolic blood pressure (mm Hg) 68 69 72
(62–76) (63–77) (65–80)
Total cholesterol (mg/dl) 190 190 194
(169–214) (169–214) (168–219)
HDL cholesterol (mg/dl) 55 55 54
(47–64) (47–65) (45–63)
Triglyceride (mg/dl) 101 100 109
(70–148) (70–148) (78–175)
Uric acid (mg/dl) 5.8 5.8 6.0
(5.1–6.6) (5.1–6.6) (5.0–6.9)
eGFR (ml/min/1.73 m2) 75.5 75.0 73.1
(69.4–82.8) (68.3–82.0) (64.7–80.5)
Fasting blood glucose (mg/dl) 89 90 94
(83–96) (84–96) (86–103)
Diabetes (%) 2 2 9
Current smoker (%) 55 55 55
Current alcohol intake (%) 72 72 70
The data are presented as medians (interquartile ranges) for continuous variables and percent
HDL, high-density lipoprotein; eGFR, estimated glomerular ﬁltration rate.[if female]) (Matsuo et al., 2009). In this study, the proteinuria using a dipstick
and eGFR were measured at baseline (2000). Diabetes mellitus was deﬁned as a
concentration of serum fasting glucose of ≥126 mg/dl or the use of glucose-
lowering medications.
Blood pressure assessment and incident hypertension
BP was measured annually with the participant in the sitting position after
5 min of rest using an automated sphygmomanometer (BP-203IIIB; Colin
Corporation, Tokyo, Japan). The BP was measured two times at intervals of
1 min on the right arm, and the average value was calculated as the baseline
BP. When a subject had frequent premature contractions or atrial ﬁbrillation,
trained nurses conﬁrmed the BP using a conventional mercury sphygmoma-
nometer. Incident hypertension was deﬁned as a newly detected BP of ≥140/
90 mm Hg and/or the initiation of antihypertensive drugs during follow-up.
Statistical analysis
All analyses were performed using the STATA software program version 11
(Stata Corp. College Station, TX, USA). Continuous variables were presented as
the medians (interquartile ranges), and differences between the two/three
groupswere evaluated using theWilcoxon test/Kruskal–Wallis analysis because
not all continuous variables were normally distributed. Categorical variables
were presented as numbers (percentages), and comparisons across the groups
were made using the chi-square test. Survival curves were calculated according
to the Kaplan–Meiermethod and compared using the log-rank test. Cox propor-
tional hazardsmodels were used to estimate the hazard ratios (HRs) of incident
hypertension according to the level of proteinuria and eGFR adjusted for
age (continuous), BMI (continuous), serum total cholesterol (continuous),
serum uric acid (continuous), diabetes mellitus (category), current smoking
(category), current alcohol intake (category) and proteinuria (category) or
eGFR (continuous), as appropriate.We used time from baseline as time variable
in the Cox models.
We assessed the independent associations of proteinuria and eGFR with in-
cident hypertension after dividing both kidney measures into three categories
(dipstick proteinuria: negative, trace and ≥1+; and eGFR: b50, 50–59.9 and
≥60 ml/min/1.73 m2). A dipstick negative status and eGFR of ≥60 ml/min/
1.73 m2 were used as reference groups. Due to the limited number of individ-
uals with an eGFR of b50 ml/min/1.73 m2 and dipstick proteinuria ≥1+, we
also tested dichotomized proteinuria (positive [trace, and ≥1+] vs. negative)2): Aichi, Japan, 2000.
p Value eGFR (ml/min/1.73 m2) p Value
(≥+)
(n = 477)
≥60
(n = 27,636)
50–59.9
(n = 1416)
b50
(n = 129)
41 (33–51) b0.001 36 (30–42) 46 (42–51) 52 (48–57) b0.001
23.3 b0.001 22.3 23.6 23.6 b0.001
(21.0–25.7) (20.6–24.3) (22.0–25.3) (21.8–25.0)
118 b0.001 114 116 120 b0.001
(110–128) (106–122) (108–124) (110–129)
74 b0.001 69 74 77 b0.001
(66–81) (63–76) (66–81) (69–84)
199 b0.001 189 206 210 b0.001
(173–225) (168–213) (185–230) (184–231)
52 b0.001 55 54 52 b0.001
(45–62) (47–65) (45–63) (44–62)
113 b0.001 100 115 121 b0.001
(77–179) (69–147) (81–169) (92–169)
6.1 b0.001 5.8 6.4 6.9 b0.001
(5.3–7.0) (5.1–6.5) (5.6–7.3) (6.1–7.7)
70.8 b0.001 75.5 56.9 47.1 b0.001
(63.0–78.8) (69.4–82.8) (55.1–58.3) (43.2–49.3)
93 b0.001 89 93 94 b0.001
(86–105) (83–96) (87–101) (88–102)
13 b0.001 2 4 9 b0.001
52 0.524 56 42 36 b0.001
66 0.027 72 75 60 0.001
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Fig. 1. A. Cumulative incidence of hypertension according to the level of proteinuria esti-
mated using a Kaplan–Meier analysis. Footnote: The blue dotted line indicates subjects
without proteinuria. The brown dotted line indicates subjects with dipstick trace protein-
uria. The green dotted line indicates subjects with dipstick ≥+ proteinuria. B. Cumulative
incidence of hypertension according to the eGFR estimated using a Kaplan–Meier analysis.
Footnote: The blue dotted line indicates subjects with an eGFR of ≥60 ml/min/1.73 m2.
The brown dotted line indicates subjects with an eGFR of 50–59.9 ml/min/1.73 m2.
The green dotted line indicates subjects with an eGFR of b50 ml/min/1.73 m2. eGFR: esti-
mated glomerular ﬁltration rate.
50 N. Okumura et al. / Preventive Medicine 60 (2014) 48–54and eGFR (reduced [b60] vs. preserved [≥60 ml/min/1.73 m2]), particularly in
the subgroup analysis.
A subgroup analysis was conducted according to the baseline BP (optimal
[systolic b 120 mm Hg and diastolic b 80 mm Hg] vs. normal or high-normal
[systolic is 120–139 mm Hg or diastolic is 80–89 mm Hg]), age (b40 vs.
≥40 years), BMI (b25 vs. ≥25 kg/m2), dyslipidemia (serum total cholesterol
b 220 vs.≥220 mg/dl), diabetes mellitus, current smoking and current alcohol
intake. The interaction terms between proteinuria and each subgroup were
assessed using likelihood ratio tests in the individual analyses. All reported
p values were two-sided, and p b 0.05 was considered to be statistically
signiﬁcant.
Results
Baseline characteristics
The baseline characteristics of the participants according to the
level of dipstick proteinuria and eGFR are shown in Table 1. Themedian
age was 35 (30–40) years, and the median eGFR was 75.5 (69.4–82.8)
ml/min/1.73 m2. There were 713 participants (2.4%) with proteinuria
(dipstick trace: n = 236, proteinuria ≥+: n = 477). The positive
proteinuria group was associated with an older age, lower eGFR and
higher prevalence of traditional cardiovascular risk factors, except for
current smoking. There were 1545 participants (5.3%) with a reduced
eGFR (50–59.9 ml/min/1.73 m2: n = 1416, 45–49.9 ml/min/1.73 m2:
n = 118, b45 ml/min/1.73 m2: n = 11). The reduced eGFR group
was associated with an older age and higher risk proﬁle of traditional
cardiovascular risk factors.
Relationship of proteinuria and eGFR with incident hypertension
During a mean follow-up period of 9.3 years (271,383 person-
years), 43.9% of the cohort (12,818 participants) developed hyperten-
sion. The number of incident hypertension cases determined by the
use of antihypertensive drugswas 2.2% (292 participants) of all incident
hypertension cases. The cumulative incidence of hypertension was
higher in the positive proteinuria group than in the negative proteinuria
group in a Kaplan–Meier analysis (negative: 43.6%; trace: 54.2%;≥1+:
61.0% in 10 years; log-rank test, p b 0.001) (Fig. 1A). Similarly, the cu-
mulative incidence of hypertension was higher in the reduced eGFR
group than in the preserved eGFR group (≥60 ml/min/1.73 m2:
43.4%; 50–59.9 ml/min/1.73 m2: 52.9%; b50 ml/min/1.73 m2: 62.8% in
10 years; log-rank test, p b 0.001) (Fig. 1B). The median duration
since test of proteinuria/reduced eGFR was 5 (2–10) years, and that of
reduced eGFR 5 (2–10) years.
The association between the two positive proteinuria categories
(trace and ≥1+) and incident hypertension remained signiﬁcant even
after adjusting for age (Table 2). Further adjustment for other potential
confounders attenuated the associations; however, the association for
proteinuria≥1+ remained signiﬁcant, even inmodel 5, which included
eGFR (adjusted HR 1.19 [95% CI, 1.06 to 1.34], p b 0.001). Notably, when
we compared positive vs. negative proteinuria, the adjusted HRwas sta-
tistically signiﬁcant, even in model 5 (1.14 [95% CI, 1.03 to 1.26],
p b 0.001). On the other hand, the association between a reduced
eGFR (≥60 ml/min/1.73 m2) and incident hypertension was more sub-
stantially attenuated by the adjustment for age. However, a signiﬁcant
association was observed for an eGFR of b50 ml/min/1.73 m2 only (vs.
≥60 ml/min/1.73 m2) after further adjustment (1.29 [95% CI, 1.03 to
1.61] in model 5, p b 0.001). We did not observe any signiﬁcant associ-
ations between a reduced eGFR (b60 ml/min/1.73 m2) and incident hy-
pertension in models 3–5 (HR 1.02 [0.95–1.10] in model 3).
Subgroup analysis
We further evaluated the association between positive proteinuria
(vs. negative proteinuria) and incident hypertension in several subgroupanalyses divided by the following parameters: baseline BP, age, BMI, di-
abetes mellitus, dyslipidemia, current smoking and current alcohol in-
take. Positive associations between positive proteinuria and incident
hypertension were observed in several of the subgroups tested, with
few signiﬁcant interactions. Of importance, the HR was signiﬁcant
among individuals with an optimal BP at baseline (b120/80 mm Hg)
(adjusted HR 1.31 [95% CI, 1.10 to 1.56], p = 0.003) (Fig. 2A). On the
other hand, a reduced eGFR of b60 ml/min/1.73 m2 was not positively
associated with the incidence of hypertension in nearly all of the
subgroups tested (Fig. 2B). A reduced eGFR of b50 ml/min/1.73 m2
(vs. eGFR ≥60 ml/min/1.73 m2) was signiﬁcantly associated with the
incidence of hypertension in several groups, with few interactions
(Fig. 2C). We conducted a sensitivity analysis BMI cut off of 23.0 kg/m2,
because the Regional Ofﬁce for Western Paciﬁc Region of WHO (WPRO
criteria) proposed a separate classiﬁcation of obesity for Asia deﬁning
adult overweight as a BMI ≥23.0 kg/m2, and got similar results (data
not shown).
Table 2
Multivariate-adjusted hazard ratios of incident hypertension according to the level of dipstick proteinuria/eGFR.
Hazard ratio (95% CI)
Model 1 Model 2 Model 3 Model 4 Model 5
Dipstick proteinuria
Negative (n = 28,468) 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference)
Trace (n = 236) 1.48 (1.24–1.76) 1.42 (1.19–1.69) 1.35 (1.13–1.60) 1.05 (0.88–1.25) 1.04 (0.88–1.24)
≥1+ (n = 477) 1.79 (1.59–2.01) 1.68 (1.49–1.88) 1.49 (1.32–1.67) 1.20 (1.06–1.35) 1.19 (1.06–1.34)
Negative (n = 28,468) 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference)
Positive (n = 713) 1.68 (1.52–1.85) 1.59 (1.44–1.75) 1.44 (1.30–1.59) 1.15 (1.04–1.27) 1.14 (1.03–1.26)
eGFR
≥60 (n = 27,636) 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference)
50–59.9 (n = 1416) 1.46 (1.35–1.57) 1.14 (1.06–1.23) 1.00 (0.93–1.08) 0.97 (0.90–1.05) 0.97 (0.90–1.05)
b50 (n = 129) 2.47 (1.99–3.07) 1.71 (1.37–2.13) 1.55 (1.25–1.94) 1.32 (1.06–1.65) 1.29 (1.03–1.61)
≥60 (n = 27,636) 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference)
≤60 (n = 1545) 1.58 (1.48–1.70) 1.15 (1.07–1.24) 1.04 (0.96–1.11) 1.00 (0.93–1.07) 0.99 (0.92–1.07)
Model 1: Crude model.
Model 2: Adjusted for age (continuous).
Model 3:Model 2 + adjusted for BMI (continuous), total cholesterol (continuous), uric acid (continuous), diabetesmellitus (yes/no), current smoking (yes/no) and current alcohol intake
(yes/no).
Model 4: Model 3 + adjusted for baseline mean BP (continuous).
Model 5: Model 4 + adjusted for eGFR (continuous) or proteinuria (positive/negative), as appropriate.
Incident hypertension was deﬁned as a newly detected BP of ≥140/90 mm Hg and/or the initiation of antihypertensive drugs.
eGFR: estimated glomerular ﬁltration rate, BMI: body mass index, BP: blood pressure.
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The present study,which employed annual blood pressuremeasure-
ment for 10 years, demonstrated that dipstick proteinuria and a re-
duced eGFR are associated with incident hypertension independently
of each other and act as potential confounders in young to middle-
aged Japanese males. The observed positive associations were consis-
tent for proteinuria in various clinical subgroups. Similarly, a signiﬁcant
association between the eGFR and the incidence of hypertension was
observed in the participants with an eGFR of b50 ml/min/1.73 m2.
When eGFR values of b60 or ≥60 ml/min/1.73 m2 were compared,
the associations were not signiﬁcant after adjusting for age and other
potential confounders.
Our results showing a positive association between proteinuria and
incident hypertension are in line with those of previous studies
(Brantsma et al., 2006; Forman et al., 2008; Gerber et al., 2006; Inoue
et al., 2006; Jessani et al., 2012; Wang et al., 2005; Wang et al., 2007)
and extend the literature in several aspects. First, we conﬁrmed the
presence of this association among a large cohort of Asian males.
Second, the association was independent of eGFR. Third, the association
remained signiﬁcant, even in the participants with an optimal BP at
baseline. Thismeans that our ﬁndings did not change after excluding in-
dividuals with latently elevated BP associatedwith proteinuria, who are
likely to develop hypertension. Fourth, we observed a consistent associ-
ation across several subgroups according to clinical risk factors, such as
age, diabetes mellitus and dyslipidemia. Finally, we were able to evalu-
ate the association for a long term of over 10 years.
There are several potential mechanisms linking proteinuria to inci-
dent hypertension. Proteinuria exerts a toxic effect on proximal tubular
epithelial cells, generating chemotactic factors, such as monocyte che-
motactic protein-1 (MCP-1) and reactive oxygen species (ROS) (Morigi
et al., 2002;Wang et al., 1999). These factors damage the renalmicrovas-
culature and tubulointerstitium, resulting in the impairment of salt
excretion and thus salt-sensitive hypertension (Johnson et al., 2002).
Additionally, protein overload in proximal tubular cells leads to the
secretion of endothelin-1, which can constrict systemic blood vessels
(Dhaun et al., 2012). Furthermore, proteinuria reﬂects systemic
endothelial dysfunction, which is known to be associated with vasocon-
striction due to a decreased level of endothelial nitric oxide (NO)
(Gkaliagkousi et al., 2009; Higashi and Chayama, 2002; Quyyumi and
Patel, 2010; Sander et al., 1999). Therefore, the presence of proteinuria
may be a harbinger of future hypertension.The law stipulates annual medical health examinations for all
workers in Japan. Dipstick urine tests have the advantage of being inex-
pensive, quick and easy to perform therefore, it can be carried out dur-
ing screening in any countries. Also, to evaluate kidney measures and
follow these markers may encourage individuals at risk for hyperten-
sion to modify their life style such as sodium intake or physical activity
at an early stage of pre-hypertension. Previous studies in Japan have
clariﬁed that the detection of proteinuria using dipstick tests in mass
screening settings is a strong, independent predictor of end-stage
renal disease (Iseki et al., 2003; Iseki et al., 2008). Measuring the level
of urinary proteins is important not only for assessing the prognosis
and diagnosis of kidney diseases (Matsushita et al., 2010; Herget-
Rosenthal et al., 2013), but also managing hypertension and diabetes
mellitus, both of which can induce nephropathy (Araki et al., 2007,
Ibsen et al., 2005). Our results suggest that the early detection of pro-
teinuriawith a simple urine dipstick testmay allow clinicians to identify
individuals at high risk for developing hypertension. In addition,
obtaining information regarding proteinuria may be useful for encour-
aging persons at high risk of hypertension to modify their lifestyle.
However, further studies are needed to evaluate whether these ap-
proaches are actually effective, particularly given the modest effect of
positive proteinuria and incident hypertension observed in our study.
In contrast to the many studies investigating the association be-
tween proteinuria and incident hypertension, the number of epidemio-
logical studies reporting an association between a reduced eGFR and
future hypertension is limited (Brantsma et al., 2006; Kestenbaum
et al., 2008; Takase et al., 2012). Two studies have reported a signiﬁcant
association between a reduced kidney function and the incidence of hy-
pertension (Kestenbaum et al., 2008; Takase et al., 2012). On the other
hand, a weaker association with incident hypertension for eGFR than
for proteinuria has been reported in the PREVEND (Prevention of
REnal and Vascular End stage Disease) Study (Brantsma et al., 2006).
Similarly, in our study, the association between an eGFR of b60
compared to ≥60 ml/min/1.73 m2 and incident hypertension was
weaker than that for positive proteinuria (vs. negative proteinuria). In
this study, the eGFR was associated with incident hypertension only
when it was lower than 50 ml/min/1.73 m2, a level recommended for
referral to a nephrologist by the Japanese Society of Nephrology (Imai
et al., 2008). However, the number of participants with an eGFR of
b60 ml/min/1.73 m2 in our study was quite small; thus, these results
should be interpreted carefully. Further investigations are needed to de-
termine what level of GFR deterioration begins to affect blood pressure.
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ment of eGFR and the use of dipstick proteinuria as ameasure of kidney
damage. Although the use of the urinary albumin-to-creatinine ratio
(UACR) is preferable, as recommended in clinical guidelines, the(n=17,592)
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Fig. 2. A.Multivariate-adjusted hazard ratios (95% CIs) of incident hypertension in the subgroup
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tinuous) and eGFR (continuous).eGFR: estimated glomerular ﬁltration rate, BMI: body mas
hypertension in the subgroups (eGFR b 60 vs. ≥60 ml/min/1.73 m2).Footnote:The HRs were a
(continuous), diabetes (yes/no), current smoking (yes/no), current alcohol intake (yes/no), bas
ular ﬁltration rate, BMI: body mass index, BP: blood pressure.C. Multivariate-adjusted hazard
1.73 m2).Footnote:The HRswere adjusted for age (continuous), BMI (continuous), total choleste
rent alcohol intake (yes/no), baseline mean BP (continuous) and proteinuria (positive/negativpresence of dipstick proteinuria has been shown to predict the future
risk of albuminuria and is considered useful for screening (Matsushita
et al., 2010). Also, we do not have data on causes of proteinuria or kid-
ney dysfunction, although the recent CKD guidelines emphasize the1.31 (1.10-1.56) 0.079
1.09 (0.97-1.23)
1.19 (1.04-1.35) 0.042
1.01 (0.87-1.19)
1.04 (0.89-1.23) 0.004
1.28 (1.13-1.45)
1.18 (0.88-1.59) 0.842
1.13 (1.02-1.26)
0.99 (0.82-1.19) 0.040
1.22 (1.09-1.38)
1.12 (0.97-1.29) 0.211
1.15 (1.00-1.33)
1.18 (1.05-1.32) 0.263
1.05 (0.87-1.26)
Hazard ratio p for interaction
0.91(0.80-1.04) 0.059
1.03(0.94-1.13)
0.94(0.87-1.02) 0.910
1.06(0.88-1.27)
1.04(0.92-1.17) 0.330
0.96(0.88-1.05)
1.26(0.91-1.75) 0.136
0.98(0.91-1.06)
0.93(0.82-1.05) 0.459
1.03(0.94-1.13)
0.95(0.85-1.07) 0.035
1.00(0.91-1.10)
0.95(0.90-1.07) 0.428
1.05(0.91-1.22)
Hazard ratio p for interaction
s (dipstick proteinuria positive vs. negative).Footnote:TheHRswere adjusted for age (con-
s/no), current smoking (yes/no), current alcohol intake (yes/no), baseline mean BP (con-
s index, BP: blood pressure.B. Multivariate-adjusted hazard ratios (95% CIs) of incident
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rol (continuous), uric acid (continuous), diabetes (yes/no), current smoking (yes/no), cur-
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53N. Okumura et al. / Preventive Medicine 60 (2014) 48–54importance of causes (KDIGO guideline, 2013). Other potential limita-
tions of this study include the following: our study population consisted
of a single race and males only. With a healthy study population, the
study might be underpowered to detect an association between re-
duced eGFR (b60 ml/min/1.73 m2) and incident hypertension. Addi-
tionally, as with any observational study, we cannot rule out the
possibility of residual unmeasured and unknown confounding factors.
Conclusion
Both proteinuria, as assessed using a dipstick strip, and a reduced
eGFR (b50 ml/min/1.73 m2) are associated with incident hypertension
independently of each other and known potential confounders. These
ﬁndings suggest that both kidney damage and kidney dysfunction
play important roles in the development of hypertension in young to
middle-aged Japanese males.
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